EUDAW
HealthcareEuda Health Holdings Ltd - Warrants (17/11/2027)
Live · NASDAQ · May 9, Close
What's Moving EUDAW Today?
No stock-specific AI insight has been generated for EUDAW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.04
Fundamentals
Trading
EUDAW News
10 articles- EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy DevelopmentGlobeNewswire Inc.·Apr 28, 2026
- EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed SecuritiesGlobeNewswire Inc.·Apr 27, 2026
- EUDA Announces Reverse Stock Split of its Ordinary SharesYahoo Finance·Mar 19, 2026
- EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock IndiaYahoo Finance·Oct 23, 2025
- EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across AsiaYahoo Finance·Oct 20, 2025
- EUDA Signs Letter of Intent to Potentially Acquire GO POSBYahoo Finance·Sep 10, 2025
- EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy PortfolioYahoo Finance·Sep 4, 2025
- EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte LtdYahoo Finance·Aug 28, 2025
- EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health SupplementYahoo Finance·Aug 26, 2025
- EUDA Health Holdings Limited (NASDAQ:EUDA) stock most popular amongst retail investors who own 47%, while private companies hold 26%Yahoo Finance·Jul 30, 2025
All 10 articles loaded
Price Data
52-Week Range
$0.04
Fundamentals
Trading
About Euda Health Holdings Ltd - Warrants (17/11/2027)
EUDA Health Holdings Limited is a dynamic biotechnology firm committed to developing cutting-edge therapies targeting dermatological and chronic health conditions. The company emphasizes scientific excellence and the integration of advanced technologies to address critical unmet medical needs, supported by a strategically prioritized pipeline of innovative products. With a seasoned leadership team focused on enhancing patient outcomes, EUDA is well-positioned to capitalize on growth opportunities in the evolving healthcare landscape.